VitaScan

VitaScan is a point-of-care diagnostics company with a mission to address significant global health challenges through the development of simple, scalable, and quantitative tests. The company's first product, IronScan, is designed to rapidly identify iron deficiency, a condition impacting a significant portion of the global population. The effects of iron deficiency are far-reaching, contributing to over 100,000 maternal deaths annually, as well as increasing the risk of miscarriage and stillbirth for 500 million women. Furthermore, an additional 500 million young children face permanent development problems due to iron deficiency during their critical early years. VitaScan's goal is to establish IronScan as the new standard of care and facilitate on-the-spot testing and treatment for individuals affected by iron deficiency. Since its inception in 2012, VitaScan has focused on the healthcare and manufacturing industries, with its headquarters located in the United States. The latest round of funding amounted to $1.00M in the form of a grant investment received on 01 April 2020. The specific investors in this round are not currently disclosed.